New Guidelines Urge Shift in Allergy Management in Israeli Schools

A new position paper released by the Israeli Association of Allergy and Clinical Immunology calls for a reevaluation of how food allergies are managed in educational institutions across Israel. The experts behind the paper argue that broad food bans in schools, while intended to protect children, may not effectively prevent anaphylaxis and can create a false sense of security. Instead, they recommend a shift towards a policy centered on professional staff training, personalized action plans for allergic students, and readily available epinephrine auto-injectors.

The paper, published under the auspices of the Israeli Medical Association and the Institute for Quality in Medicine, highlights that while severe allergic reactions like anaphylaxis are rare, they require immediate treatment with adrenaline and medical attention. It also emphasizes that the primary risk for a systemic reaction comes from ingesting the allergen, with skin contact typically causing localized reactions and smells posing no allergic risk. Exposure through airborne food proteins is considered uncommon.

Beyond the physical risks, the paper acknowledges the significant psychological toll food allergies can take on individuals and their families, citing Israeli research that links food allergies and anaphylaxis to anxiety, depression, and other psychological burdens. Misconceptions about exposure routes can exacerbate this anxiety, making accurate risk assessment and understanding crucial for safe management.

In the educational setting, where approximately 10% of food allergy reactions occur, the paper challenges the efficacy of blanket bans on certain allergens. It suggests that these bans may not be sufficient to reduce anaphylaxis risk and can foster an unrealistic belief in a completely allergen-free environment. The proposed alternative involves tailoring protective measures to the specific needs of each child and the school's environment, rather than relying solely on general prohibitions.

Key recommendations include developing individualized emergency plans for each allergic student, ensuring staff are trained by professionals to recognize and treat reactions promptly, and making epinephrine auto-injectors accessible. The paper also suggests reconsidering the current model of personal aides, which are often limited to younger grades, and exploring options like training school staff as "health liaisons" or increasing the presence of school nurses.

Professor Yuval Tal, Chairman of the Israeli Association of Allergy and Clinical Immunology, stressed that the goal is not to downplay the risks but to enhance protection through professional, evidence-based strategies that also allow children to develop independence. The association advocates for a standardized professional training program for the education system and a public awareness campaign to clarify allergic reactions and emergency procedures.